Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Lori Gardner, ACCC

Advertisement

Articles by Lori Gardner, ACCC

Association of Community Cancer Centers to Honor Seven Cancer Programs with Innovator Awards at 35th National Oncology Conference

ByLori Gardner, ACCC
August 27th 2018

Hundreds of oncology professionals will gather in Phoenix, Arizona, to share best practices and creative approaches that address the most pressing issues facing cancer programs in communities around the country.

Advertisement

Latest Updated Articles

  • Association of Community Cancer Centers to Honor Seven Cancer Programs with Innovator Awards at 35th National Oncology Conference
    Association of Community Cancer Centers to Honor Seven Cancer Programs with Innovator Awards at 35th National Oncology Conference

    August 27th 2018



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses

2

ASCO Releases First Living Guideline for Recurrent Ovarian Cancer Care

3

FDA Approves Rusfertide, First-in-Class Hepcidin Mimetic for Polycythemia Vera

4

Dose Modifications and Where Monotherapy Still Fits

5

Weighing Early Toxicity Against Long-Term Survival Benefit

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us